dipyridamole has been researched along with fluorobenzenes in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Boerman, OC; Dekker, D; Meijer, P; Oyen, WJ; Rongen, GA; Scheffer, GJ; Smits, P; van den Broek, PH; Wouters, CW | 1 |
| Dunselman, PH; Slart, RH; Tio, RA; van den Heuvel, AF; van der Harst, P; van Veldhuisen, DJ; Voors, AA; Willemsen, AT | 1 |
2 trial(s) available for dipyridamole and fluorobenzenes
| Article | Year |
|---|---|
Rosuvastatin increases extracellular adenosine formation in humans in vivo: a new perspective on cardiovascular protection.
Topics: Adenosine; Administration, Oral; Annexin A5; Caffeine; Dipyridamole; Dose-Response Relationship, Drug; Double-Blind Method; Female; Fluorobenzenes; Forearm; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Infusions, Intra-Arterial; Male; Nitroprusside; Pyrimidines; Radionuclide Imaging; Regional Blood Flow; Reperfusion Injury; Rosuvastatin Calcium; Sulfonamides; Time Factors; Up-Regulation; Vasodilation; Vasodilator Agents | 2009 |
Effects of rosuvastatin on coronary flow reserve and metabolic mismatch in patients with heart failure (from the CORONA Study).
Topics: Aged; Aged, 80 and over; Biomarkers; C-Reactive Protein; Cholesterol, HDL; Cholesterol, LDL; Coronary Circulation; Dipyridamole; Exercise Test; Female; Fluorobenzenes; Fluorodeoxyglucose F18; Heart Failure; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Lipoproteins; Male; Myocardium; Netherlands; Pilot Projects; Pyrimidines; Radiopharmaceuticals; Rosuvastatin Calcium; Sulfonamides; Tomography, Emission-Computed; Vasodilator Agents | 2010 |